Intermediate for Efinaconazole. Efinaconazole (trade names: Jublia and Clenafin) is a 14α-demethylase inhibitor for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole has been approved by the U.S Food and Drug Administration on June 6, 2014.


Product Name:                  1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole

Synonyms:                         N/A

CAS Number:                     127000-90-2

Molecular Weight:            251.2352

Molecular Formula:          C12H11F2N3O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Fc1ccc(c(c1)F)[C@@]1(Cn2cncn2)O[C@H]1C


  • $208.00
  • Ex Tax: $208.00

Available Options